Korsana Biosciences, Inc. (KRSA) is in Healthcare, Biotechnology, based in United States, listed on NasdaqCM. Market cap 1.53B USD. 52-week range 7.19 to 59.36 USD. Data as of 2026-10-09.
Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of large therapeutic molecules across the blood-brain barrier into the central nervous system. The company advances a pipeline of THETA-enabled therapeutics with an initial focus on ...